Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.34 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.34 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1028644 | 1.00 | TSHR (0.46) | TSHRTHRBALDH1A1ZDHHC20ZDHHC2 | |
| SCHEMBL1031768 | 1.00 | TSHR (0.46) | TSHRTHRBALDH1A1ZDHHC20ZDHHC2 | |
| SCHEMBL3096180 | 0.89 | TSHR (0.41) | TSHRTHRBALDH1A1LMNA | |
| SCHEMBL5457905 | 0.79 | TSHR (0.46) | TSHRTHRBALDH1A1ZDHHC20ZDHHC2 | |
| SCHEMBL15018875 | 0.79 | TSHR (0.46) | TSHRTHRBALDH1A1ZDHHC20ZDHHC2 | |
| Heptane SCHEMBL28181693 | 0.71 | TSHR (0.55) | TSHRTHRBALDH1A1DNM1LMNA | |
| Decane SCHEMBL4518816 | 0.70 | TSHR (0.61) | TSHRTHRBALDH1A1DNM1LMNA | |
| Octane SCHEMBL4515243 | 0.70 | TSHR (0.61) | TSHRTHRBALDH1A1DNM1LMNA | |
| Heptane SCHEMBL11697610 | 0.70 | TSHR (0.61) | TSHRTHRBALDH1A1DNM1LMNA | |
| Octane SCHEMBL28971016 | 0.70 | TSHR (0.61) | TSHRTHRBALDH1A1DNM1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150080581-A1 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | RIMTEC CORPORATION (JP) | 2015-03-19 | — | — | US | disclosed |
| US-8927670-B2 | Multicoordinated metal complexes for use in metathesis reactions | RIMTEC CORPORATION (JP) | 2015-01-06 | — | — | US | disclosed |
| EP-2397475-B1 | 4, 4' disubstituted 4H-cyclopentadithiophene and new methods for synthesising the same | IMEC (BE) | 2014-11-12 | — | — | EP | disclosed |
| US-8765882-B2 | Polythiophene based active layer for solar cells | IMEC (BE) | 2014-07-01 | — | — | US | disclosed |
| US-8450604-B2 | Polymerisable compounds for making opto-electronic devices | IMEC (BE) | 2013-05-28 | — | — | US | disclosed |
| US-8329923-B2 | 4, 4′ disubstituted 4H-cyclopentadithiophene and new methods for synthesizing the same | IMEC (BE) | 2012-12-11 | — | — | US | disclosed |
| US-20120279569-A1 | POLYTHIOPHENE BASED ACTIVE LAYER FOR SOLAR CELLS | UNIVERSITEIT HASSELT (BE) | 2012-11-08 | — | — | US | disclosed |
| EP-2509972-A1 | POLYMERS COMPRISING 3 -SUBSTITUTED THIOPHENE MOIETIES AS ACTIVE LAYERS FOR SOLAR CELLS | IMEC (BE) | 2012-10-17 | — | — | EP | disclosed |
| EP-2307398-B1 | POLYMERISABLE COMPOUNDS FOR MAKING OPTO-ELECTRONIC DEVICES | IMEC (BE) | 2012-09-05 | — | — | EP | disclosed |
| US-20110313175-A1 | 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME | UNIVERSITEIT HASSELT (BE) | 2011-12-22 | — | — | US | disclosed |
| EP-2397475-A1 | 4, 4' disubstituted 4H-cyclopentadithiophene and new methods for synthesising the same | IMEC (BE) | 2011-12-21 | — | — | EP | disclosed |
| WO-2011069554-A1 | POLYMERS COMPRISING 3 -SUBSTITUTED THIOPHENE MOIETIES AS ACTIVE LAYERS FOR SOLAR CELLS | IMEC (BE) | 2011-06-16 | — | — | WO | disclosed |
| US-20110130522-A1 | POLYMERISABLE COMPOUNDS FOR MAKING OPTO-ELECTRONIC DEVICES | UNIVERSITEIT HASSELT (BE) | 2011-06-02 | — | — | US | disclosed |
| EP-2307398-A1 | POLYMERISABLE COMPOUNDS FOR MAKING OPTO-ELECTRONIC DEVICES | IMEC (BE) | 2011-04-13 | — | — | EP | disclosed |
| EP-1757613-B1 | Multicoordinated metal complexes for use in metathesis reactions | TELENE SAS (FR) | 2011-01-19 | — | — | EP | disclosed |
| WO-2010000504-A1 | POLYMERISABLE COMPOUNDS FOR MAKING OPTO-ELECTRONIC DEVICES | INTERUNIVERSITAIR MICROELEKTRONICA CENTRUM (BE) | 2010-01-07 | — | — | WO | disclosed |
| US-20080293905-A9 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | RIMTEC CORPORATION (JP) | 2008-11-27 | — | — | US | disclosed |
| WO-2007022945-A2 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | VIACATT N.V. (BE) | 2007-03-01 | — | — | WO | disclosed |
| EP-1757613-A1 | Multicoordinated metal complexes for use in metathesis reactions | Viacatt N.V. (BE) | 2007-02-28 | — | — | EP | disclosed |
| US-20070043188-A1 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | TELENE S.A.S. (FR) | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150080581-A1 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | APEX1, SOD1, AP1M1 | TSHR 4417/4885THRB 4749/4885ALDH1A1 1713/4885 |
| US-20120279569-A1 | POLYTHIOPHENE BASED ACTIVE LAYER FOR SOLAR CELLS | SCO2, CLTB, CLTC | TSHR 4501/4885THRB 4127/4885ALDH1A1 2933/4885 |
| US-20110313175-A1 | 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME | DDT, NISCH, DBH | TSHR 784/4885THRB 166/4885ALDH1A1 2561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.